ZA855365B - Pharmaceutical formulations for ceftazidime - Google Patents

Pharmaceutical formulations for ceftazidime

Info

Publication number
ZA855365B
ZA855365B ZA855365A ZA855365A ZA855365B ZA 855365 B ZA855365 B ZA 855365B ZA 855365 A ZA855365 A ZA 855365A ZA 855365 A ZA855365 A ZA 855365A ZA 855365 B ZA855365 B ZA 855365B
Authority
ZA
South Africa
Prior art keywords
ceftazidime
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
ZA855365A
Other languages
English (en)
Inventor
Alan Lee Fites
Michael Jon Pikal
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24540922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA855365(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA855365B publication Critical patent/ZA855365B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA855365A 1984-07-23 1985-07-16 Pharmaceutical formulations for ceftazidime ZA855365B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63373984A 1984-07-23 1984-07-23

Publications (1)

Publication Number Publication Date
ZA855365B true ZA855365B (en) 1987-02-25

Family

ID=24540922

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA855365A ZA855365B (en) 1984-07-23 1985-07-16 Pharmaceutical formulations for ceftazidime

Country Status (7)

Country Link
EP (1) EP0169700B1 (de)
JP (1) JPS6137728A (de)
CA (1) CA1249969A (de)
DE (1) DE3577656D1 (de)
IL (1) IL75800A (de)
NZ (1) NZ212763A (de)
ZA (1) ZA855365B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
RU2284832C2 (ru) * 2004-08-30 2006-10-10 Николай Александрович Киселев Антимикробная композиция для перорального введения
CN108272753A (zh) * 2018-02-07 2018-07-13 宁夏天心医药有限责任公司 一种头孢他啶粉针制剂及其制法
CN113101274B (zh) * 2021-03-31 2022-09-06 海南海灵化学制药有限公司 一种注射用头孢他啶粉针剂及其制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5519237A (en) * 1978-07-27 1980-02-09 Toa Iyakuhin Kogyo Kk Crystalline lactose with high beta-lactose content and diluent comprising it
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
DE3577656D1 (de) 1990-06-21
IL75800A0 (en) 1985-11-29
EP0169700A3 (en) 1987-05-13
EP0169700A2 (de) 1986-01-29
JPS6137728A (ja) 1986-02-22
CA1249969A (en) 1989-02-14
EP0169700B1 (de) 1990-05-16
IL75800A (en) 1988-11-30
NZ212763A (en) 1987-11-27

Similar Documents

Publication Publication Date Title
GB2153678B (en) Pharmaceutical composition
DE3378523D1 (en) Pharmaceutical formulations
EP0163178A3 (en) Pharmaceutical composition
ZA824513B (en) Pharmaceutical formulations
GB2153677B (en) Pharmaceutical composition
GB8623389D0 (en) Pharmaceutical formulations
ZA855365B (en) Pharmaceutical formulations for ceftazidime
DE3466477D1 (en) Pharmaceutical formulations
ZA859077B (en) Pharmaceutical compounds
GB2153676B (en) Pharmaceutical composition
GB8419107D0 (en) Pharmaceutical formulations
GB8421741D0 (en) Pharmaceutical formulations
GB8421737D0 (en) Pharmaceutical formulations
ZA833692B (en) Pharmaceutical formulations
GB8603031D0 (en) Pharmaceutical formulations
IL91357A0 (en) Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides
GB8316496D0 (en) Pharmaceutical formulations
GB8316498D0 (en) Pharmaceutical formulations
GB8300648D0 (en) Pharmaceutical formulations
GB8313036D0 (en) Pharmaceutical formulations
GB8316495D0 (en) Pharmaceutical formulations
GB8316497D0 (en) Pharmaceutical formulations
GB8332451D0 (en) Pharmaceutical formulations
GB8319759D0 (en) Pharmaceutical formulations
GB8319760D0 (en) Pharmaceutical formulations